Medpace
MEDP
597 hedge funds and large institutions have $10.2B invested in Medpace in 2024 Q1 according to their latest regulatory filings, with 95 funds opening new positions, 185 increasing their positions, 249 reducing their positions, and 38 closing their positions.
150% more first-time investments, than exits
New positions opened: 95 | Existing positions closed: 38
62% more call options, than puts
Call options by funds: $83M | Put options by funds: $51.1M
34% more capital invested
Capital invested by funds: $7.65B → $10.2B (+$2.57B)
10% more funds holding
Funds holding: 544 → 597 (+53)
0.92% more ownership
Funds ownership: 81.36% → 82.28% (+0.92%)
8% less funds holding in top 10
Funds holding in top 10: 13 → 12 (-1)
26% less repeat investments, than reductions
Existing positions increased: 185 | Existing positions reduced: 249
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FPP
Findlay Park Partners
London,
United Kingdom
|
+$78.5M |
| 2 |
ClearBridge Investments
New York
|
+$68.8M |
| 3 |
Prudential Financial
Newark,
New Jersey
|
+$59.3M |
| 4 |
Goldman Sachs
New York
|
+$55.3M |
| 5 |
D.E. Shaw & Co
New York
|
+$49.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$109M |
| 2 |
BTW
Boston Trust Walden
Boston,
Massachusetts
|
-$77.8M |
| 3 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$74.5M |
| 4 |
Fuller & Thaler Asset Management
San Mateo,
California
|
-$44.7M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$35M |
MEDP Hedge Fund Activity: Q1 2024 in Review
597 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Medpace (MEDP) for Q1 2024, worth a combined $10.2B — up 34% from $7.65B a quarter earlier.
Buyers outnumbered sellers: 95 funds opened new MEDP positions and 38 closed out — a net gain of 57 holders — while 185 added to existing stakes and 249 trimmed.
The largest buyer was Findlay Park Partners, opening a new position worth an estimated $78.5M. The largest seller was Morgan Stanley, cutting an estimated $109M.
- 597 institutional investors held Medpace (MEDP) as of Q1 2024, up from 544 in Q4 2023.
- Funds reported $10.2B of Medpace stock for Q1 2024, up 34% quarter-over-quarter.
- 95 funds opened new Medpace positions in Q1 2024 and 38 closed out, a net change of +57 holders.
- The largest Medpace buyer in Q1 2024 was Findlay Park Partners, an estimated $78.5M added.
- The largest Medpace seller in Q1 2024 was Morgan Stanley, an estimated $109M sold.
Based on aggregated 13F filings for Q1 2024.